Han B - Search Results

1

Expert consensus of management of adverse drug reactions with anaplastic lymphoma kinase tyrosine kinase inhibitors.

Zhou F, Yang Y, Zhang L, Cheng Y, Han B, Lu Y, Wang C, Wang Z, Yang N, Fan Y, Wang L, Ma Z, Zhang L, Yao Y, Zhao J, Dong X, Zhu B, Zhou C. Zhou F, et al. Among authors: han b. ESMO Open. 2023 Jun;8(3):101560. doi: 10.1016/j.esmoop.2023.101560. Epub 2023 May 23. ESMO Open. 2023. PMID: 37230029 Free PMC article. Review.

2

[Advances in Sengers syndrome].

Fan P, Lu YT, Han B, Zhou XL, Tian T. Fan P, et al. Among authors: han b. Zhonghua Nei Ke Za Zhi. 2023 Oct 1;62(10):1245-1248. doi: 10.3760/cma.j.cn112138-20221029-00801. Zhonghua Nei Ke Za Zhi. 2023. PMID: 37766448 Chinese.

3

High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study.

Yang Y, Hu Q, Yang C, Chen M, Han B. Yang Y, et al. Among authors: han b. Hematology. 2024 Dec;29(1):2298523. doi: 10.1080/16078454.2023.2298523. Epub 2023 Dec 29. Hematology. 2024. PMID: 38156735 Free article.

4

COVID-19 vaccination prevents a more severe course and treatment with complement inhibitors reduce worsening hemolysis during the Omicron pandemic in patients with PNH: a single-center study.

Wang L, Hu Q, Yang Y, Chen M, Yang C, Han B. Wang L, et al. Among authors: han b. Ann Med. 2023;55(2):2274510. doi: 10.1080/07853890.2023.2274510. Epub 2024 Jan 1. Ann Med. 2023. PMID: 38163328 Free PMC article.

5

[Eculizumab in patients with paroxysmal nocturnal hemoglobinuria: a real-world study in China].

Wang LY, Hu QL, Chen M, Yang C, Han B. Wang LY, et al. Among authors: han b. Zhonghua Xue Ye Xue Za Zhi. 2024 Feb 14;45(2):184-189. doi: 10.3760/cma.j.cn121090-20231106-00250. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 38604796 Chinese.

6

Cyclosporine plus avatrombopag versus cyclosporine monotherapy for first-line treatment of elderly patients with transfusion-dependent non-severe aplastic anemia: a single center retrospective study.

Zhang Z, Hu Q, Wang L, Yang C, Chen M, Han B. Zhang Z, et al. Among authors: han b. Ann Med. 2024 Dec;56(1):2424451. doi: 10.1080/07853890.2024.2424451. Epub 2024 Nov 12. Ann Med. 2024. PMID: 39529509 Free PMC article.

7

Ligubenzocycloheptanone A, a Novel Tricyclic Butenolide with a 6/7/5 Skeleton from Ligusticum chuanxiong.

Han B, Zhang X, Feng ZM, Jiang JS, Li L, Yang YN, Zhang PC. Han B, et al. Sci Rep. 2016 Jul 27;6:28783. doi: 10.1038/srep28783. Sci Rep. 2016. PMID: 27461841 Free PMC article.

8

Ferulic acid derivatives from Ligusticum chuanxiong.

Zhang X, Han B, Feng ZM, Yang YN, Jiang JS, Zhang PC. Zhang X, et al. Among authors: han b. Fitoterapia. 2018 Mar;125:147-154. doi: 10.1016/j.fitote.2018.01.005. Epub 2018 Jan 19. Fitoterapia. 2018. PMID: 29358153

9

Bioactive thionic compounds and aromatic glycosides from Ligusticum chuanxiong.

Zhang X, Han B, Feng Z, Jiang J, Yang Y, Zhang P. Zhang X, et al. Among authors: han b. Acta Pharm Sin B. 2018 Sep;8(5):818-824. doi: 10.1016/j.apsb.2018.04.002. Epub 2018 Apr 11. Acta Pharm Sin B. 2018. PMID: 30245968 Free PMC article.

10

Chemical constituents of Ligusticum chuanxiong and their anti-inflammation and hepatoprotective activities.

Yuan X, Han B, Feng ZM, Jiang JS, Yang YN, Zhang PC. Yuan X, et al. Among authors: han b. Bioorg Chem. 2020 Aug;101:104016. doi: 10.1016/j.bioorg.2020.104016. Epub 2020 Jun 17. Bioorg Chem. 2020. PMID: 32599365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,867 results

Search Page

Filters